Capital Group Investment Management Pte. Ltd. Gilead Sciences, Inc. Transaction History
Capital Group Investment Management Pte. Ltd.
- $503 Million
- Q4 2024
A detailed history of Capital Group Investment Management Pte. Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Capital Group Investment Management Pte. Ltd. holds 8,666 shares of GILD stock, worth $982,291. This represents 0.16% of its overall portfolio holdings.
Number of Shares
8,666
Previous 12,681
31.66%
Holding current value
$982,291
Previous $1.06 Million
24.67%
% of portfolio
0.16%
Previous 0.22%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
2,101Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$13.1 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8.13 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.84 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.57 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $142B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...